OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.Something looks off?
Open jobs at OmniaBio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.